

          1. Refusal to sign informed consent form

          2. Any previous positive test for COVID-19 by PCR

          3. Symptomatic for COVID-19

          4. Diarrhea

          5. Type I or II diabetes

          6. Atherosclerotic Coronary Artery Disease

          7. Any contraindication for treatment with Plaquenil

          8. Any comorbidities which, in the opinion of the investigator, constitute health risk
             for the subject. These include congestive heart failure, cardiac arrhythmia, prior
             malignancy other than non-melanoma skin cancer, HIV positive, Hepatitis B Surface
             Antigen Positive, Hepatitis C, Inflammatory bowel disease, Tuberculosis, and any
             significant infection. Any other condition that in the investigator's opinion should
             not be enrolled.
      